Related Experiment Video
Updated: Jun 19, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Clinical implications of vulnerable plaque
Jeffrey S Berger1, John L Petersen, James E Tcheng
1Duke University Medical Center, Durham, NC, USA. jeffrey.berger@duke.edu
Insights
Identifying vulnerable plaques and patients is key to reducing deaths from coronary artery disease (CAD). New imaging tools improve risk assessment for better treatment strategies against this leading cause of mortality.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging
- Atherosclerosis Research
Background:
- Coronary artery disease (CAD) remains the leading cause of death in the USA, often presenting as fatal acute heart attacks.
- Despite advances in medical therapy and interventional cardiology, mortality rates from CAD persist.
- Identifying vulnerable plaques and patients is crucial for effective disease management.
Purpose of the Study:
- To highlight the importance of identifying vulnerable plaques and patients in combating coronary artery disease.
- To discuss the role of advancements in diagnostic studies and novel imaging tools.
- To emphasize the potential for improved risk stratification in managing CAD.
Main Methods:
- Review of current diagnostic studies and novel imaging technologies for plaque vulnerability.
- Analysis of risk stratification methods, both noninvasive and invasive.
- Discussion on the implications for systemic and local treatment strategies.
Main Results:
- Improved diagnostic capabilities and imaging tools offer significant advances in vulnerable plaque management.
- Enhanced risk stratification allows for better assessment of risk/benefit for novel therapies.
- Accurate identification of vulnerable plaque can guide more effective systemic and local treatments.
Conclusions:
- Identifying vulnerable plaques and patients is essential for reducing morbidity and mortality associated with coronary artery disease.
- Advancements in imaging and diagnostics are critical for improving patient outcomes.
- Targeted treatments based on plaque vulnerability assessment hold promise for future therapeutic strategies.
Abstract:
In many individuals, the first indicator of atherosclerosis is an acute heart attack, which is often fatal. Despite innovations in medical therapy and interventional cardiology techniques, coronary artery disease continues to be the leading cause of death in the USA. There is great interest in identifying vulnerable plaques and vulnerable patients as a possible means to stem the tide against coronary artery disease. Improvements in diagnostic studies and development of novel imaging tools have opened the possibilities for significant advances in the management of vulnerable plaque. The result of improved risk stratification, by both noninvasive and invasive means, will be a better assessment of the risk/benefit relationships for the novel therapies that are needed to further reduce the morbidity and mortality of the disease. Correct identification of vulnerable plaque would permit the use of more effective systemic treatment and enable clinical trials to study the supplemental benefit from local treatments.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
